2179 — Jiangsu Recbio Technology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Jiangsu Recbio Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,183	1,325	912	448	352
Net Total Accounts Receivable
Net Total Receivables	51.9	12.6	38.6	93.9	134
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,295	1,420	1,129	655	538
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	511	814	1,003	1,162	1,125
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,919	2,310	2,186	1,940	1,762
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	139	329	444	839	538
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	246	648	1,115	1,411	1,056
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	1,673	1,662	1,071	529	706
Total Liabilities & Shareholders' Equity	1,919	2,310	2,186	1,940	1,762
Total Common Shares Outstanding